Skip to main content

Dr. Thomas L. Johnson II, M.D.

Allergy & Immunology (Allergy & Immunology Physician)

  • Medicare participating

At a glance

In the NPI registry since
2006
Medicare patients seen, 2024
721

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Allergy & Immunology Physician primary
    FL license ME101774

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Allergy & Immunology per capita by county →

Medicare patients and services

Medicare patients, 2024
721
Services billed
42,774
Patients’ average age
74
Most frequent Medicare services, 2023
ServiceTimesPatients
Test for allergy using allergenic extract22,411333
Injection, omalizumab, 5 mg10,39833
Test for allergy using skin patch4,01357
Professional service for multiple injections of allergen2,370316
Professional service for preparation and provision of 1 or more antigens2,280151
Professional service for single injection of allergen1,25095
Injection of drug or substance under skin or into muscle64270
Established patient office or other outpatient visit, 30-39 minutes513417
New patient office or other outpatient visit, 45-59 minutes391391
Administration and interpretation of patient-focused health risk assessment358309

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 10 companies reported 26 payments worth $12,261 in total to this clinician.

By company
AstraZeneca Pharmaceuticals LP$11,995
Regeneron Healthcare Solutions, Inc.$75.40
Csl Behring$42.69
Takeda Pharmaceuticals U.S.A., Inc.$29.38
Pfizer Inc.$24.97
Ars Pharmaceuticals Operations, Inc.$21.86
Grifols USA, LLC$19.80
Greer Laboratories, Inc.$18.99
By type
Compensation for services other than consulting (speaking, faculty)$11,150
Food and Beverage$608
Travel and Lodging$503

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Feb 10, 2025AstraZeneca Pharmaceuticals LP
Feb 10, 2025
Compensation for services other than consulting (speaking, faculty)
AIRSUPRA · Respiratory
Company’s descriptionSpeaker Fee
$3,700
Jan 29, 2025AstraZeneca Pharmaceuticals LP
Jan 29, 2025
Compensation for services other than consulting (speaking, faculty)
AIRSUPRA · Respiratory
Company’s descriptionSpeaker Fee
$2,800
Mar 24, 2025AstraZeneca Pharmaceuticals LP
Mar 24, 2025
Compensation for services other than consulting (speaking, faculty)
AIRSUPRA · Respiratory
Company’s descriptionSpeaker Fee
$2,350
Mar 18, 2025AstraZeneca Pharmaceuticals LP
Mar 18, 2025
Compensation for services other than consulting (speaking, faculty)
AIRSUPRA · Respiratory
Company’s descriptionSpeaker Fee
$1,850
Feb 18, 2025AstraZeneca Pharmaceuticals LP
Feb 18, 2025
Compensation for services other than consulting (speaking, faculty)
AIRSUPRA · Respiratory
Company’s descriptionSpeaker Fee
$450
Feb 4, 2025AstraZeneca Pharmaceuticals LP
Feb 4, 2025
Travel and Lodging
AIRSUPRA · Respiratory · travel to Savannah, GA · in-kind
Company’s descriptionSpeaker Expenses
$340
Mar 13, 2025AstraZeneca Pharmaceuticals LP
Mar 13, 2025
Travel and Lodging
AIRSUPRA · Respiratory · travel to Lake Mary, FL · in-kind
Company’s descriptionSpeaker Expenses
$96.60
Jan 23, 2025AstraZeneca Pharmaceuticals LP
Jan 23, 2025
Travel and Lodging
AIRSUPRA · Respiratory · travel to Mount Dora, FL · in-kind
Company’s descriptionSpeaker Expenses
$65.80

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Florida →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $7,272 in research payments for these studies, mostly to the institutions running them.

  • Ph iii study to evaluate the efficacy and safety of astegolimab in copd
    Genentech, Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Allergy & Immunology clinicians in Gainesville

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 19, 2024), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1255399226. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.